BDO Sunghyun announced that Gil-bae Yoon was appointed as a new CEO. Graduating from Korea University, Gil-bae Yoon received an MA degree in accounting from Korea University Graduate School and a Ph.D. degree in accounting from Suwon University. He is an expert in audit and assurance with over 25 years of experience at PwC …
An analysis on the ‘pandemic effect’ which explains how intentions for ‘sustainable travel’ come to fruition 83% of global travelers think sustainable travel is vital, with 61% saying the pandemic has made them want to travel more sustainably in the future Even though 3 out of 4 accommodation partners say they have implemented sustainable steps …
With regard to vaccination, the Office of the Foreign Investment Ombudsman compiled frequently asked questions coming to our office, and we sincerely hope that the following information would be informative to you. Please note that the government’s policies are keep changing according to COVID-19 outbreaks and vaccination process in Korea, so it is recommended to …
Accor Ambassador Korea launches the Summer Offer 2+1 Promotion for vacationers to enjoy the summer holiday, plus a weekday getaway after summer. Guests who book two consecutive nights in one of 17 participating Accor Ambassador Hotels will gain a one-night staying voucher for the next staycation. Promotion is bookable from 14 June to 30 August …
Acquisition Fundraiser 1. Job Description Under the direct supervision of the Acquisition Manager, the Acquisition Fundraiser implements acquisition plans to acquire new donors, and improves operational excellence of new acquisition to support the achievement of fundraising objectives and strategies. The new Acquisition Fundraiser provides administrative support to all acquisition activities and closely works with the …
Merck is all about science and technology. In 2021, we offer a series of research grants(read more) to stimulate innovative research in challenging areas of future importance. We intend to provide research grants in several areas of up to 450,000€ per year for up to 3 years with the option of extension or expansion. Drug …